336 related articles for article (PubMed ID: 29600597)
1. MMP7 cleaves remyelination-impairing fibronectin aggregates and its expression is reduced in chronic multiple sclerosis lesions.
Wang P; Gorter RP; de Jonge JC; Nazmuddin M; Zhao C; Amor S; Hoekstra D; Baron W
Glia; 2018 Aug; 66(8):1625-1643. PubMed ID: 29600597
[TBL] [Abstract][Full Text] [Related]
2. Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
Stoffels JM; de Jonge JC; Stancic M; Nomden A; van Strien ME; Ma D; Sisková Z; Maier O; Ffrench-Constant C; Franklin RJ; Hoekstra D; Zhao C; Baron W
Brain; 2013 Jan; 136(Pt 1):116-31. PubMed ID: 23365094
[TBL] [Abstract][Full Text] [Related]
3. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
Qin J; Sikkema AH; van der Bij K; de Jonge JC; Klappe K; Nies V; Jonker JW; Kok JW; Hoekstra D; Baron W
J Neurosci; 2017 Oct; 37(41):9925-9938. PubMed ID: 28899916
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin aggregates promote features of a classically and alternatively activated phenotype in macrophages.
Sikkema AH; Stoffels JMJ; Wang P; Basedow FJ; Bulsink R; Bajramovic JJ; Baron W
J Neuroinflammation; 2018 Aug; 15(1):218. PubMed ID: 30071854
[TBL] [Abstract][Full Text] [Related]
5. The EIIIA domain from astrocyte-derived fibronectin mediates proliferation of oligodendrocyte progenitor cells following CNS demyelination.
Stoffels JM; Hoekstra D; Franklin RJ; Baron W; Zhao C
Glia; 2015 Feb; 63(2):242-56. PubMed ID: 25156142
[TBL] [Abstract][Full Text] [Related]
6. Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination.
Schultz V; van der Meer F; Wrzos C; Scheidt U; Bahn E; Stadelmann C; Brück W; Junker A
Glia; 2017 Aug; 65(8):1350-1360. PubMed ID: 28560740
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination.
Shen K; Reichelt M; Kyauk RV; Ngu H; Shen YA; Foreman O; Modrusan Z; Friedman BA; Sheng M; Yuen TJ
Cell Rep; 2021 Mar; 34(10):108835. PubMed ID: 33691116
[TBL] [Abstract][Full Text] [Related]
8. Remodeling of the interstitial extracellular matrix in white matter multiple sclerosis lesions: Implications for remyelination (failure).
de Jong JM; Wang P; Oomkens M; Baron W
J Neurosci Res; 2020 Jul; 98(7):1370-1397. PubMed ID: 31965607
[TBL] [Abstract][Full Text] [Related]
9. E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord.
Church JS; Milich LM; Lerch JK; Popovich PG; McTigue DM
Glia; 2017 Jun; 65(6):883-899. PubMed ID: 28251686
[TBL] [Abstract][Full Text] [Related]
10. Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system.
Rawji KS; Young AMH; Ghosh T; Michaels NJ; Mirzaei R; Kappen J; Kolehmainen KL; Alaeiilkhchi N; Lozinski B; Mishra MK; Pu A; Tang W; Zein S; Kaushik DK; Keough MB; Plemel JR; Calvert F; Knights AJ; Gaffney DJ; Tetzlaff W; Franklin RJM; Yong VW
Acta Neuropathol; 2020 May; 139(5):893-909. PubMed ID: 32030468
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases shape the oligodendrocyte (niche) during development and upon demyelination.
Gorter RP; Baron W
Neurosci Lett; 2020 Jun; 729():134980. PubMed ID: 32315713
[TBL] [Abstract][Full Text] [Related]
12. Butyrate suppresses demyelination and enhances remyelination.
Chen T; Noto D; Hoshino Y; Mizuno M; Miyake S
J Neuroinflammation; 2019 Aug; 16(1):165. PubMed ID: 31399117
[TBL] [Abstract][Full Text] [Related]
13. TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis.
Cignarella F; Filipello F; Bollman B; Cantoni C; Locca A; Mikesell R; Manis M; Ibrahim A; Deng L; Benitez BA; Cruchaga C; Licastro D; Mihindukulasuriya K; Harari O; Buckland M; Holtzman DM; Rosenthal A; Schwabe T; Tassi I; Piccio L
Acta Neuropathol; 2020 Oct; 140(4):513-534. PubMed ID: 32772264
[TBL] [Abstract][Full Text] [Related]
14. Lesion stage-dependent causes for impaired remyelination in MS.
Heß K; Starost L; Kieran NW; Thomas C; Vincenten MCJ; Antel J; Martino G; Huitinga I; Healy L; Kuhlmann T
Acta Neuropathol; 2020 Sep; 140(3):359-375. PubMed ID: 32710244
[TBL] [Abstract][Full Text] [Related]
15. Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery.
van Schaik PEM; Zuhorn IS; Baron W
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955549
[TBL] [Abstract][Full Text] [Related]
16. Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.
Lombardi M; Parolisi R; Scaroni F; Bonfanti E; Gualerzi A; Gabrielli M; Kerlero de Rosbo N; Uccelli A; Giussani P; Viani P; Garlanda C; Abbracchio MP; Chaabane L; Buffo A; Fumagalli M; Verderio C
Acta Neuropathol; 2019 Dec; 138(6):987-1012. PubMed ID: 31363836
[TBL] [Abstract][Full Text] [Related]
17. Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin.
Keough MB; Jensen SK; Yong VW
J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867716
[TBL] [Abstract][Full Text] [Related]
18. Laquinimod Supports Remyelination in Non-Supportive Environments.
Nyamoya S; Steinle J; Chrzanowski U; Kaye J; Schmitz C; Beyer C; Kipp M
Cells; 2019 Oct; 8(11):. PubMed ID: 31683658
[TBL] [Abstract][Full Text] [Related]
19. Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
[TBL] [Abstract][Full Text] [Related]
20. The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia.
Mecha M; Yanguas-Casás N; Feliú A; Mestre L; Carrillo-Salinas F; Azcoitia I; Yong VW; Guaza C
Brain Behav Immun; 2019 Mar; 77():110-126. PubMed ID: 30582962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
